Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks

NCT05445557 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Flank Mass

Interventions

DRUG: RZL-012
DRUG: Placebo

Sponsor

Raziel Therapeutics Ltd.